Cost containment through pharmaceutical procurement: a Caribbean case study

Area of Science:

• Health Economics
• Pharmaceutical Policy
• Public Health Procurement

Background:

• Developing countries face challenges in health sector cost containment.
• Pharmaceutical procurement is a significant area for potential cost savings.
• Small island nations often have unique procurement hurdles.

Purpose of the Study:

• To analyze the cost-saving mechanisms of the Eastern Caribbean Drug Service (ECDS) in pharmaceutical procurement.
• To identify key elements of successful pooled procurement for health sector cost containment.
• To provide a replicable model for other developing countries.

Main Methods:

• Case study analysis of the Eastern Caribbean Drug Service (ECDS).
• Examination of ten critical components of the ECDS procurement operation.
• Evaluation of strategies including demand pooling, restricted tendering, and standardization.

Main Results:

• ECDS achieved over 50% reduction in pharmaceutical unit costs in its first procurement cycle.
• Key factors included political will, demand pooling, and strategic supplier negotiations.
• Standardization of products and effective contract management were crucial.

Conclusions:

• Pooled pharmaceutical procurement offers substantial cost-saving potential for developing countries.
• The ECDS model provides a practical blueprint for improving health sector efficiency.
• Adaptable strategies can enhance pharmaceutical access and affordability globally.